Lung cancer remains a significant public health problem in 2006, despite efforts aimed at educating individuals about the dangers of tobacco and the successes of smoking cessation programs. No screening methods aimed at high risk individuals are currently supported by the National Cancer Institute or other medical organizations. Since the risk for lung cancer persists even after smoking cessation, studies of methods to detect lung cancer in its early stages, when it is amenable to cure, are clearly needed. This study examined a novel method of sputum collection and processing to determine whether the adequacy of the samples collected was improved over conventional preparation methods. We also examined lung function as a possible predictor of cytologic abnormality in the sputum of individuals at high risk for lung cancer, and studied the potential of a molecular biomarker for the early detection of lung cancer. This study employed a cross-sectional design and utilized quantitative methods for exploring the relationships between the variables, particularly those of lung function, cytologic diagnosis and gene mutation status, with personal risk factors for developing lung cancer. This study demonstrated an association between lung function and cytologic diagnosis of moderate or worse atypia in the sputum collected from these participants and examined at the University of Colorado. We also demonstrated a higher rate of sputum specimen adequacy than has been previously reported from conventional clinical experience. We examined the feasibility of conducting somatic gene mutation analysis on the samples collected by this novel method. We achieved some success in studying K-ras mutations, but were unsuccessful in our analysis of DNA methylation. From these experiences we have gathered information upon which to base further studies.
The importance of these findings from a public health perspective is that there is an opportunity for early detection of lung cancer via analysis of cellular and molecular changes in sputum. We have demonstrated that the Thin Prep® methodology, applied to sputum, produces material suitable for cytologic examination and, under certain circumstances, material suitable for molecular analysis. Patients at high risk for lung cancer will benefit from continued research into novel screening methods.
| Identifer | oai:union.ndltd.org:PITT/oai:PITTETD:etd-05312006-074907 |
| Date | 08 August 2006 |
| Creators | Simon, Mary Beth |
| Contributors | Jill Siegfried, Ph.D., Stephen Raab, MD, Joel Weissfeld, MD, MPH, H. Samuel Wieand, Ph.D., Evelyn Talbott, Dr, PH |
| Publisher | University of Pittsburgh |
| Source Sets | University of Pittsburgh |
| Language | English |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | http://etd.library.pitt.edu/ETD/available/etd-05312006-074907/ |
| Rights | unrestricted, I hereby certify that, if appropriate, I have obtained and attached hereto a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to University of Pittsburgh or its agents the non-exclusive license to archive and make accessible, under the conditions specified below, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report. |
Page generated in 0.0019 seconds